Case Study: Reimbursement Strategy for Lifesaving Cervical Dilator
The ADVI Health Reimbursement team assisted a client in negotiating a reimbursement strategy for a new cervical dilator product aimed to reduce pre-term labor and cesareans. Hear more from Michael Beebe, executive vice president, as he shares some insights from this successful project.
Video Transcript
Melyssa: In 280 characters, or less, describe a project you engaged in this year which yielded results that you’re proud of.
Michael: I think everybody’s probably heard the news about the United States having the highest maternal and child mortality rates among high-income countries. We worked with a client to get the Centers for Medicare and Medicaid Services to consent to review payment for a new cervical dilator product, a superior product that’s used in labor and delivery. This product is expected to benefit both women and children by allowing women to stay out of the hospital until they absolutely need to give birth. It’s also expected to reduce the rate of cesarean section and premature deliveries. We are very excited about that.
Learn More
Stay ahead of the curve. Get in touch today to gain expert insights and strategic counsel on the evolving healthcare landscape.
CEO insights
Related articles
Real analysis from people who’ve been there
Remote Therapeutic Monitoring
ADVI worked with the client and the AMA’s Digital Medicine Payment Advisory Committee to develop new CPT codes for remote therapeutic monitoring.
Cardiovascular Technologies
Reviewed primary clinical study literature and, based on published Medicare precedents and processes, produced mock National Coverage Determinations on several invasive cardiovascular technologies, applying typical CMS standards and formats.
Lumbar Spine Stenosis Device
ADVI worked with the client and CMS to reverse a negative draft NCD and obtained a final NCD with CED that required a randomized clinical study.
Non-Opioid Device Pain Relief Product
Assessed the positioning of a client's non-opioid pain relief device versus competitive products, including drugs and other devices used to treat pain.
AI Device for Osteoporosis Assessment
ADVI helped a client obtain a new Category I CPT code for the trabecular bone score AI software device.
Osseochondral Knee Implant
ADVI analyzed the reimbursement environment for a novel osseochondral implant under development to determine whether existing codes and payment would be sufficient for the new device.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.